Aberration of the HGF/c-MET system is well documented in several human cancers [11], such as non-small cell lung cancer (NSCLC), squamous cell carcinoma of the head and neck (HNSCC) cancer, as well as other carcinomas. This evidence concerns the gene MET and head and neck squamous cell carcinoma.